ClinicalTrials.Veeva

Menu

Outpatient Recovery From Acute Kidney Injury Requiring Dialysis (ORKID)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status and phase

Terminated
Phase 4

Conditions

Acute Kidney Injury
Dialysis Hypotension

Treatments

Drug: Furosemide
Other: ORKID Bundled Intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT05158153
21-33602

Details and patient eligibility

About

There are currently no therapies to improve the chances of recovering enough kidney function to come off of dialysis after severe acute kidney injury. It is not known if current routine outpatient dialysis treatments are optimized to maximize the chances of recovery. The purpose of this pilot study is to see if we can feasibly and safely provide several changes to the way that dialysis is provided in outpatient dialysis centers which may improve the chances of recovery.

Enrollment

1 patient

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • AKI-D (acute kidney injury requiring dialysis), attributed at least in part to acute tubular necrosis by clinical nephrology team
  • Age ≥ 18 years
  • Pre-hospitalization eGFR ≥ 15 mL/min/1.73m2
  • Being discharged to a participating outpatient dialysis unit (within 30 miles of UCSF)

Exclusion criteria

  • Known loop diuretic allergy/intolerance
  • Dialysis duration > 3 months
  • Pregnant
  • Prisoner
  • Unable to consent
  • Clinical team declines to allow approach for study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1 participants in 1 patient group

ORKID Bundled Intervention
Experimental group
Treatment:
Drug: Furosemide
Other: ORKID Bundled Intervention

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems